v3.26.1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Assets    
Investments, at fair value $ 1,553,547 [1] $ 1,536,368 [2]
Cash and cash equivalents 30,698 32,963
Foreign currency (amortized cost—$1,016 and $576, respectively) 1,009 577
Receivable for investments sold and repaid 7,855 205
Income receivable 8,358 6,737
Unrealized appreciation on foreign currency forward contracts 6 194
Deferred financing costs 9,099 5,263
Prepaid expenses and other assets 183 1,220
Total assets 1,610,755 1,583,527
Liabilities    
Payable for investments purchased 6,815 16,984
Debt 572,938 604,062
Unrealized depreciation on foreign currency forward contracts 199 221
Shareholders’ distributions payable 7,094 6,456
Management fees payable 3,141 2,766
Subordinated income incentive fees payable 2,775 836
Accrued capital gains incentive fee 0 1,576
Administrative services expense payable 813 202
Distribution/servicing fees payable 664 640
Accrued accounting and administrative fees 298 149
Interest payable 8,349 5,376
Other accrued expenses and liabilities 1,611 642
Total liabilities 604,697 639,910
Commitments and contingencies (Note 10)
Shareholders’ equity    
Common Shares, $0.01 par value, unlimited shares authorized, 40,509,275 and 36,891,563 Class S shares issued and outstanding, respectively 405 369
Capital in excess of par value 1,030,569 938,087
Retained earnings (accumulated deficit) (24,916) 5,161
Total shareholders’ equity 1,006,058 943,617
Total liabilities and shareholders’ equity $ 1,610,755 $ 1,583,527
Net asset value per share of common shares at period end (in dollars per share) $ 24.84 $ 25.58
Non-controlled/unaffiliated investments    
Assets    
Investments, at fair value $ 1,492,641 $ 1,513,290
Non-controlled/Affiliated Investments    
Assets    
Investments, at fair value 10,155 3,578
Controlled/Affiliated Investments    
Assets    
Investments, at fair value $ 50,751 $ 19,500
[1] See Note 8 for additional information regarding the fair value of the Company’s financial instruments.
[2] See Note 8 for additional information regarding the fair value of the Company’s financial instruments.